MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • 2017 International Congress

    Evaluating Use of the DBS Patient Programmer

    D. Whitney, J. Karl, G. Pal, D. Ocegueda-Ramirez, B. Ouyang, L. Verhagen Metman (Chicago, IL, USA)

    Objective: To characterize use of the Medtronic® DBS patient programmer among patients with DBS for movement disorders. Background: Patients who undergo deep brain stimulation receive…
  • 2017 International Congress

    Study in Parkinson’s Disease of Exercise (SPARX): A Randomized, Controlled Futility Trial

    D. Corcos, C. Moore, W. Kohrt, D. Hall, A. Delitto, C. Comella, D. Josbeno, C. Christiansen, B. Berman, B. Kluger, E. Melanson, S. Jain, J. Robichaud, C. Poon, M. Schenkman (Chicago, IL, USA)

    Objective: Our first objective was to determine whether people with de novo Parkinson’s disease (PD) are able to exercise at either 60-65% maximal heart rate…
  • 2017 International Congress

    Using the power of a Network to accomplish a Countrywide Review of Acute Parkinson’s Disease management

    E. Peter, B. Mohamed, C. Thomas (Bridgend, United Kingdom)

    Objective: To undertake a review of acute Parkinson’s management across different sites in Wales, a country that is part of the United Kingdom with a…
  • 2017 International Congress

    Evaluation of rotigotine transdermal patch in combination with low or high dose levodopa in patients with Parkinson’s disease: post-hoc analysis

    E. Dohin, F. Woltering, M. Asgharnejad (Brussels, Belgium)

    Objective: To investigate the value of adding the dopamine agonist (DA) rotigotine (RTG) to low (<400mg/day) or high (≥400mg/day) levodopa (Ldopa) doses in patients with…
  • 2017 International Congress

    Gait, Freezing of Gait and Falls detection using wearable sensors; a systematic review

    A.L. Silvade Lima, L.JW. Evers, T. Hahn, L. Bataille, J.L. Hamilton, M.A. Little, B.R. Bloem, M.J. Faber (Nijmegen, Netherlands)

    Objective: An overview of the use of wearable systems to assess gait, freezing of gait (FOG) and falls in patients with Parkinson’s disease (PD).  Background:…
  • 2017 International Congress

    The Critical Path for Parkinson’s Consortium: Understanding Motor Disease Progression Through Quantitative Medicine

    K. Romero, D. Conrado, B. Corrigan, K. Tsai, M. Ahamadi, S. Macha, V. Sinha, I. Watson, M. Bani, P. Muglia, V. Kern, C. Williams-Gray, D. Grosset, M. Hu, D. Burn, R. Lawson, K. Marek, A. Roach, D. Stephenson, T. Nicholas (Tucson, AZ, USA)

    Objective: Develop a quantitative tool to optimize the definition of entry criteria, enrichment strategies and stratification approaches, and submit for formal regulatory endorsement at FDA…
  • 2017 International Congress

    Treadmill training, Tai Chi, dance and more: a meta-analysis on the effectiveness of different physiotherapy modalities in Parkinson’s disease

    D. Radder, N. de Vries, M. Faber, M. van Nimwegen, S. Keus, B. Bloem (Nijmegen, Netherlands)

    Objective: Physiotherapy (PT) is widely recognized as an intervention for people with Parkinson’s disease (PD). Many controlled trials have evaluated conventional PT, and the evidence…
  • 2017 International Congress

    Efficacy and Safety of Therapeutic Interventions to Treat Motor Symptoms in Late Stage Parkinson’s Disease: A Systematic Review

    M. Coelho, K. Destri, M. Fabbri, A. Schrag, J. Ferreira, b.C. Consortium (Lisbon, Portugal)

    Objective: Evaluate the efficacy and safety of therapeutic interventions to treat the motor symptoms in late stage PD. Background: PD patients in late stage are…
  • 2017 International Congress

    Barriers to exercise in newly diagnosed Parkinson’s disease

    I. Argyropoulos, E. Pearson, F. Murphy, V. Queen, J. Rideout, C. Carrollq (Plymouth, United Kingdom)

    Objective: To evaluate and understand the perceived benefits and barriers towards physical activity in newly-diagnosed people with Parkinson’s disease (PwP). Background: The evidence base to…
  • 2017 International Congress

    Exercise preferences of people with Parkinson’s disease: preliminary findings of a discrete choice experiment

    C. Canning, C. Canning, S. Paul, J. Bampton, C. Sherrington, K. Howard (Lidcombe, Sydney, Australia)

    Objective: To identify which exercise program attributes most commonly drive willingness of people with Parkinson’s disease (PD) to participate in evidence-based exercise programs. Background: A…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley